Background: Current guidelines for screening of colorectal cancer do not offer specific recommendations for cessation of antithrombotic agents prior to fecal occult blood test (FOBT). Aim ...

[19] This study was limited by failure to establish the reliability of the bililabstix as a test for occult blood, failure to blind the test results, and retrospective patient classification.